TransMedics Group, Inc.
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditā¦ read more
Healthcare
Medical Devices
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$68.45
Price+1.36%
$0.92
1Y
Price
Market Cap
$2.366b
Mid
Price/Earnings 3y Avg5y Avg
15.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+14.5%
EBITDA Margin+4.2%
Net Profit Margin-7.0%
Free Cash Flow Margin+14.5%
EBITDA Margin+4.2%
Net Profit Margin-7.0%
Free Cash Flow MarginRevenue
$635.890m
+5.0%
1y CAGR+41.6%
3y CAGR+70.9%
5y CAGREarnings
$171.924m
-9.6%
1y CAGR+222.9%
3y CAGR+174.9%
5y CAGREPS
$4.37
-10.3%
1y CAGR+201.0%
3y CAGR+160.1%
5y CAGRBook Value
$494.007m
$1.435b
Assets$940.813m
Liabilities$818.750m
DebtDebt to Assets
57.1%
6x
Debt to EBITDAFree Cash Flow
$151.358m
+13.3%
1y CAGR+112.1%
3y CAGR+25.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company